S&P 500   2,605.92 (-0.79%)
DOW   22,182.52 (-0.65%)
QQQ   191.84 (-0.10%)
AAPL   256.08 (+0.50%)
FB   167.73 (+1.07%)
MSFT   159.98 (-0.16%)
GOOGL   1,153.52 (+0.63%)
AMZN   1,967.88 (+0.20%)
CGC   14.69 (+1.59%)
NVDA   263.00 (-0.98%)
BABA   194.14 (+1.50%)
MU   43.35 (-2.63%)
GE   7.97 (+1.01%)
TSLA   529.51 (+5.45%)
AMD   47.02 (-1.76%)
T   29.54 (-2.28%)
ACB   0.92 (+3.39%)
F   5.02 (+0.00%)
NFLX   375.24 (+1.15%)
BAC   22.03 (-0.05%)
GILD   74.92 (-1.33%)
DIS   99.63 (-0.17%)
S&P 500   2,605.92 (-0.79%)
DOW   22,182.52 (-0.65%)
QQQ   191.84 (-0.10%)
AAPL   256.08 (+0.50%)
FB   167.73 (+1.07%)
MSFT   159.98 (-0.16%)
GOOGL   1,153.52 (+0.63%)
AMZN   1,967.88 (+0.20%)
CGC   14.69 (+1.59%)
NVDA   263.00 (-0.98%)
BABA   194.14 (+1.50%)
MU   43.35 (-2.63%)
GE   7.97 (+1.01%)
TSLA   529.51 (+5.45%)
AMD   47.02 (-1.76%)
T   29.54 (-2.28%)
ACB   0.92 (+3.39%)
F   5.02 (+0.00%)
NFLX   375.24 (+1.15%)
BAC   22.03 (-0.05%)
GILD   74.92 (-1.33%)
DIS   99.63 (-0.17%)
S&P 500   2,605.92 (-0.79%)
DOW   22,182.52 (-0.65%)
QQQ   191.84 (-0.10%)
AAPL   256.08 (+0.50%)
FB   167.73 (+1.07%)
MSFT   159.98 (-0.16%)
GOOGL   1,153.52 (+0.63%)
AMZN   1,967.88 (+0.20%)
CGC   14.69 (+1.59%)
NVDA   263.00 (-0.98%)
BABA   194.14 (+1.50%)
MU   43.35 (-2.63%)
GE   7.97 (+1.01%)
TSLA   529.51 (+5.45%)
AMD   47.02 (-1.76%)
T   29.54 (-2.28%)
ACB   0.92 (+3.39%)
F   5.02 (+0.00%)
NFLX   375.24 (+1.15%)
BAC   22.03 (-0.05%)
GILD   74.92 (-1.33%)
DIS   99.63 (-0.17%)
S&P 500   2,605.92 (-0.79%)
DOW   22,182.52 (-0.65%)
QQQ   191.84 (-0.10%)
AAPL   256.08 (+0.50%)
FB   167.73 (+1.07%)
MSFT   159.98 (-0.16%)
GOOGL   1,153.52 (+0.63%)
AMZN   1,967.88 (+0.20%)
CGC   14.69 (+1.59%)
NVDA   263.00 (-0.98%)
BABA   194.14 (+1.50%)
MU   43.35 (-2.63%)
GE   7.97 (+1.01%)
TSLA   529.51 (+5.45%)
AMD   47.02 (-1.76%)
T   29.54 (-2.28%)
ACB   0.92 (+3.39%)
F   5.02 (+0.00%)
NFLX   375.24 (+1.15%)
BAC   22.03 (-0.05%)
GILD   74.92 (-1.33%)
DIS   99.63 (-0.17%)
Log in

NYSE:AZN - AstraZeneca Stock Price, Forecast & News

$44.37
-0.16 (-0.36 %)
(As of 03/31/2020 12:37 PM ET)
Today's Range
$43.86
Now: $44.37
$45.11
50-Day Range
$37.79
MA: $45.30
$50.17
52-Week Range
$36.15
Now: $44.37
$51.55
Volume5.02 million shs
Average Volume6.45 million shs
Market Capitalization$116.44 billion
P/E Ratio83.72
Dividend Yield4.38%
Beta0.56
AstraZeneca PLC discovers, develops, and commercializes prescription medicines in the areas of oncology, cardiovascular, renal and metabolism, respiratory, autoimmunity, infection, neuroscience, and gastroenterology worldwide. Its marketed products include Arimidex, Casodex/Cosudex, Calquence, Faslodex, Imfinzi, Iressa, Lynparza, Nolvadex, Tagrisso, and Zoladex for oncology diseases; Atacand1/Atacand HCT/Atacand Plus, Brilinta/Brilique, Crestor, Plendil, Seloken/Toprol-XL, Tenormin, and Zestril for cardiovascular diseases; and Bydureon, Byetta, Farxiga/Forxiga, Kombiglyze XR, Komboglyze, Onglyza, Qtern, Symlin, Xigduo, and Xigduo XR for metabolic diseases. The company's marketed products also comprise Accolate, Bevespi Aerosphere, Bricanyl Respules, Bricanyl Turbuhaler, Daliresp/Daxas, Duaklir Genuair, Eklira Genuair/Tudorza Pressair, Fasenra, Oxis Turbuhaler, Pulmicort Turbuhaler/Pulmicort Flexhaler, Pulmicort Respules, Symbicort pMDI, Symbicort Turbuhaler, and Tudorza Pressair for respiratory diseases; Fluenz FluMist/Tetra Quadrivalen and Synagis3 for infection diseases; Movantik/Moventig, Seroquel IR, Seroquel XR, and Vimovo for neuroscience diseases; and Losec/Prilosec and Nexium for gastrointestinal diseases. The company serves primary care and specialty care physicians through distributors and local representative offices. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was founded in 1992 and is headquartered in Cambridge, the United Kingdom.
Read More
AstraZeneca logo

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
CUSIPN/A
Phone44-20-3749-5000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$24.38 billion
Cash Flow$3.31 per share
Book Value$5.56 per share

Profitability

Net Income$1.34 billion

Miscellaneous

Employees64,400
Outstanding Shares2,624,370,000
Market Cap$116.44 billion
Next Earnings Date4/24/2020 (Estimated)
OptionableOptionable

Receive AZN News and Ratings via Email

Sign-up to receive the latest news and ratings for AZN and its competitors with MarketBeat's FREE daily newsletter.


AstraZeneca (NYSE:AZN) Frequently Asked Questions

How has AstraZeneca's stock been impacted by COVID-19 (Coronavirus)?

AstraZeneca's stock was trading at $44.58 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, AZN stock has decreased by 0.5% and is now trading at $44.37. View which stocks have been mosted impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of AstraZeneca?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for AstraZeneca in the last year. There are currently 2 sell ratings, 2 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for AstraZeneca.

When is AstraZeneca's next earnings date?

AstraZeneca is scheduled to release its next quarterly earnings announcement on Friday, April 24th 2020. View our earnings forecast for AstraZeneca.

How were AstraZeneca's earnings last quarter?

AstraZeneca plc (NYSE:AZN) issued its quarterly earnings data on Friday, February, 14th. The company reported $0.45 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.53 by $0.08. The business had revenue of $6.66 billion for the quarter, compared to analyst estimates of $6.75 billion. AstraZeneca had a net margin of 5.38% and a return on equity of 32.24%. The firm's revenue was up 3.8% on a year-over-year basis. During the same period last year, the firm earned $1.58 earnings per share. View AstraZeneca's earnings history.

How often does AstraZeneca pay dividends? What is the dividend yield for AstraZeneca?

AstraZeneca announced a semi-annual dividend on Tuesday, February 18th. Investors of record on Friday, February 28th will be paid a dividend of $0.95 per share on Monday, March 30th. This represents a dividend yield of 2.8%. The ex-dividend date of this dividend is Thursday, February 27th. View AstraZeneca's dividend history.

When did AstraZeneca's stock split? How did AstraZeneca's stock split work?

AstraZeneca's stock split on Monday, July 27th 2015. The 2-1 split was announced on Friday, June 26th 2015. The newly created shares were payable to shareholders after the market closes on Friday, July 24th 2015. An investor that had 100 shares of AstraZeneca stock prior to the split would have 200 shares after the split.

What price target have analysts set for AZN?

6 Wall Street analysts have issued 12-month target prices for AstraZeneca's stock. Their forecasts range from $40.73 to $55.00. On average, they anticipate AstraZeneca's share price to reach $48.58 in the next twelve months. This suggests a possible upside of 9.5% from the stock's current price. View analysts' price targets for AstraZeneca.

Has AstraZeneca been receiving favorable news coverage?

News articles about AZN stock have trended very positive this week, InfoTrie reports. InfoTrie rates the sentiment of press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. AstraZeneca earned a daily sentiment score of 3.2 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the near term. View the latest news aboutAstraZeneca.

Are investors shorting AstraZeneca?

AstraZeneca saw a decline in short interest in the month of March. As of March 13th, there was short interest totaling 7,174,500 shares, a decline of 20.0% from the February 27th total of 8,970,000 shares. Based on an average trading volume of 3,080,000 shares, the short-interest ratio is presently 2.3 days. Approximately 0.3% of the company's stock are sold short. View AstraZeneca's Current Options Chain.

Who are some of AstraZeneca's key competitors?

What other stocks do shareholders of AstraZeneca own?

Based on aggregate information from My MarketBeat watchlists, some companies that other AstraZeneca investors own include Pfizer (PFE), AT&T (T), AbbVie (ABBV), Bank of America (BAC), Gilead Sciences (GILD), Cisco Systems (CSCO), Micron Technology (MU), Merck & Co., Inc. (MRK), Bristol-Myers Squibb (BMY) and NVIDIA (NVDA).

Who are AstraZeneca's key executives?

AstraZeneca's management team includes the following people:
  • Mr. Pascal Soriot, CEO & Exec. Director (Age 60)
  • Mr. Marc Dunoyer, CFO & Exec. Director (Age 67)
  • Ms. Pam P. Cheng, Exec. Vice-Pres of Operations & Information Technology (Age 48)
  • Thomas Kudsk Larsen, Head of Investor Relations
  • Mr. Jefrey Pott, Gen. Counsel

What is AstraZeneca's stock symbol?

AstraZeneca trades on the New York Stock Exchange (NYSE) under the ticker symbol "AZN."

How do I buy shares of AstraZeneca?

Shares of AZN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is AstraZeneca's stock price today?

One share of AZN stock can currently be purchased for approximately $44.37.

How big of a company is AstraZeneca?

AstraZeneca has a market capitalization of $116.44 billion and generates $24.38 billion in revenue each year. The company earns $1.34 billion in net income (profit) each year or $1.75 on an earnings per share basis. AstraZeneca employs 64,400 workers across the globe. View additional information about AstraZeneca.

What is AstraZeneca's official website?

The official website for AstraZeneca is http://www.astrazeneca.com/.

How can I contact AstraZeneca?

AstraZeneca's mailing address is 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS, CAMBRIDGE X0, CB2 0AA. The company can be reached via phone at 44-20-3749-5000 or via email at [email protected]


MarketBeat Community Rating for AstraZeneca (NYSE AZN)

Community Ranking:  1.9 out of 5 (star)
Outperform Votes:  739 (Vote Outperform)
Underperform Votes:  1,229 (Vote Underperform)
Total Votes:  1,968
MarketBeat's community ratings are surveys of what our community members think about AstraZeneca and other stocks. Vote "Outperform" if you believe AZN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AZN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/31/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel